PREVALENCE OF POLYCYSTIC OVARIAN SYNDROME AMONG YOUNG WOMEN WHO ATTENDED TERTIARY CARE HOSPITAL, VISAKHAPATNAM

KSK DIVYA; BNV MOUNISHA; R. VELAGAPUDI SOWMYA

doi:10.22159/ijcpr.2024v16i4.5026

Authors

KSK DIVYA Department of Obstetrics and Gynaecology, GITAM Institute of Medical Sciences and Research, GITAM Deemed to be University, Rushikonda, Visakhapatnam, India
BNV MOUNISHA Department of Obstetrics and Gynaecology, GITAM Institute of Medical Sciences and Research, GITAM Deemed to be University, Rushikonda, Visakhapatnam, India
R. VELAGAPUDI SOWMYA Department of Obstetrics and Gynaecology, GITAM Institute of Medical Sciences and Research, GITAM Deemed to be University, Rushikonda, Visakhapatnam, India

DOI:

https://doi.org/10.22159/ijcpr.2024v16i4.5026

Keywords:

PCOS, BMI, Hirsutism, Rotterdam criteria, Lifestyle

Abstract

Objective: The present study aimed to determine the prevalence of PCOS among young adults attended to medical OP in a Tertiary care teaching hospital.

Materials: It is a retrospective study conducted in a Tertiary care teaching hospital, Visakhapatnam using existing records in the Department of Obstetrics and Gynaecology. The study was conducted from July 2021 to July 2023. The study population includes young adults of age in between 18-30 y. PCOS was defined by Rotterdam's criteria having presence of any two of the three features. Hormonal assays were conducted using immunoradiometric assay for TSH, LH, FSH.

Results: Majority of the PCOS cases 39% were reported in the age group of 26-30 Y. Among the 100 cases reported, the majority of them are reported with menstrual irregularity 62%. However, it was identified from the results that the mean values of cholesterol and triglycerides levels are quite higher suggested hyperlipidemia. The hormonal levels of TSH, LH and FSH were normal.

Conclusion: Although the overall frequency of PCOS is low and evaluating PCOS in young adults can be difficult, the condition is becoming more common at this age. Changes in lifestyle are essential at this age to avoid long-term metabolic and reproductive issues.

Downloads

Download data is not yet available.

References

Bharali MD, Rajendran R, Goswami J, Singal K, Rajendran V. Prevalence of polycystic ovarian syndrome in India: a systematic review and meta-analysis. Cureus. 2022 Dec 9;14(12):e32351. doi: 10.7759/cureus.32351, PMID 36628015, PMCID PMC9826643.

Dennett CC, Simon J. The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment. Diabetes Spectr. 2015 May;28(2):116-20. doi: 10.2337/diaspect.28.2.116, PMID 25987810, PMCID PMC4433074.

Cunha A, Povoa AM. Infertility management in women with polycystic ovary syndrome: a review. Porto Biomed J. 2021 Jan 26;6(1):e116. doi: 10.1097/j.pbj.0000000000000116, PMID 33532657, PMCID PMC7846416.

Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020 Oct-Dec;13(4):261-71. doi: 10.4103/jhrs.JHRS_95_18, PMID 33627974, PMCID PMC7879843.

Khan MJ, Ullah A, Basit S. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives. Appl Clin Genet. 2019 Dec 24;12:249-60. doi: 10.2147/TACG.S200341, PMID 31920361, PMCID PMC6935309.

De leo V, Musacchio MC, Cappelli V, Massaro MG, Morgante G, Petraglia F. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol. 2016 Jul 16;14(1):38. doi: 10.1186/s12958-016-0173-x, PMID 27423183, PMCID PMC4947298.

Purwar A, Nagpure S. Insulin resistance in polycystic ovarian syndrome. Cureus. 2022 Oct 16;14(10):e30351. doi: 10.7759/cureus.30351, PMID 36407241, PMCID PMC9665922.

Barber TM, Hanson P, Weickert MO, Franks S. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019 Sep 9;13:1179558119874042. doi: 10.1177/1179558119874042, PMID 31523137, PMCID PMC6734597.

McCartney CR, Campbell RE, Marshall JC, Moenter SM. The role of gonadotropin-releasing hormone neurons in polycystic ovary syndrome. J Neuroendocrinol. 2022 May;34(5):e13093. doi: 10.1111/jne.13093, PMID 35083794, PMCID PMC9232905.

Marques P, Skorupskaite K, Rozario KS, Anderson RA, George JT. Physiology of GnRH and gonadotropin secretion. In: Endotext; Updated 2022 Jan 5 Feingold KR, Anawalt B, Blackman MR. South Dartmouth. Text. Com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279070/ [Last accessed on 24 Jun 2024]

Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016 Oct;37(5):467-520. doi: 10.1210/er.2015-1104, PMID 27459230, PMCID PMC5045492.

Witchel SF, Oberfield SE, Pena AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls [presentation]. J Endocr Soc. 2019 Jun 14;3(8):1545-73. doi: 10.1210/js.2019-00078, PMID 31384717, PMCID PMC6676075.

Saadia Z. Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS)–obese vs. non-obese women. Med Arch. 2020 Aug;74(4):289-93. doi: 10.5455/medarh.2020.74.289-293, PMID 33041447, PMCID PMC7520057.

Christ JP, Cedars MI. Current guidelines for diagnosing PCOS. Diagnostics (Basel). 2023 Mar 15;13(6):1113. doi: 10.3390/diagnostics13061113, PMID 36980421, PMCID PMC10047373.

Ganie MA, Rashid A, Sahu D, Nisar S, Wani IA, Khan J. Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: a cross-sectional study. Int J Gynaecol Obstet. 2020 May;149(2):231-6. doi: 10.1002/ijgo.13125, PMID 32080845.

Deswal R, Nanda S, Ghalaut VS, Roy PS, Dang AS. Cross-sectional study of the prevalence of polycystic ovary syndrome in rural and urban populations. Int J Gynaecol Obstet. 2019 Sep;146(3):370-9. doi: 10.1002/ijgo.12893, PMID 31220344.

Rao VS, Cowan S, Armour M, Smith CA, Cheema BS, Moran L. A global survey of ethnic Indian women living with polycystic ovary syndrome: co-morbidities, concerns, diagnosis experiences, quality of life, and use of treatment methods. Int J Environ Res Public Health. 2022 Nov 28;19(23):15850. doi: 10.3390/ijerph192315850, PMID 36497927, PMCID PMC9740300.

Borgia F, Cannavo S, Guarneri F, Cannavo SP, Vaccaro M, Guarneri B. Correlation between endocrinological parameters and acne severity in adult women. Acta Derm Venereol. 2004;84(3):201-4. doi: 10.1080/00015550410023248, PMID 15202836.

Bahri Khomami M, Joham AE, Boyle JA, Piltonen T, Arora C, Silagy M. The role of maternal obesity in infant outcomes in polycystic ovary syndrome-A systematic review, meta-analysis, and meta-regression. Obes Rev. 2019a;20(6):842-58. doi: 10.1111/obr.12832, PMID 30785659.

Barber TM, Hanson P, Weickert MO, Franks S. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042. doi: 10.1177/1179558119874042, PMID 31523137.

Cena H, Chiovato L, Nappi RE. Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists. J Clin Endocrinol Metab. 2020;105(8):e2695-709. doi: 10.1210/clinem/dgaa285, PMID 32442310.

Fan H, Ren Q, Sheng Z, Deng G, Li L. The role of the thyroid in polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023 Oct 5;14:1242050. doi: 10.3389/fendo.2023.1242050, PMID 37867519, PMCID PMC10585146.

PREVALENCE OF POLYCYSTIC OVARIAN SYNDROME AMONG YOUNG WOMEN WHO ATTENDED TERTIARY CARE HOSPITAL, VISAKHAPATNAM

Authors

DOI:

Keywords:

Abstract

Downloads

References

Published

How to Cite

Issue

Section